期刊文献+
共找到251篇文章
< 1 2 13 >
每页显示 20 50 100
Epidemiology of fatal cases associated with pandemic influenza reported in Yemen
1
作者 Ahmed A. K. Thabet Najeeb M. Moulhee +1 位作者 Abdulhakeem Al-kohlani Mohammed Jahaf 《Natural Science》 2012年第11期803-807,共5页
Objectives: This study describes the incidence of all fatal cases associated with Pandemic Influenza A (H1N1) in Yemen. It sets out to highlight the factors associated with poor prognosis *The authors declare that the... Objectives: This study describes the incidence of all fatal cases associated with Pandemic Influenza A (H1N1) in Yemen. It sets out to highlight the factors associated with poor prognosis *The authors declare that they have no competing interests. to enhance the implementation of prevention and control programs. Methods: The study is based on retrospective analysis of available data until 14 March 2010, as compiled by the disease control and surveillance team in Yemen. Results: Between 16 June 2009 and 14 March 2010, a total of 33 laboratory-confirmed death cases associated with pandemic influenza A (H1N1) were reported to the Diseases Control and Surveillance in the Ministry of Public Health and Population. During this period, a total of 6049 suspected influenza A (H1N1) cases were recorded. With this denominator, the case fatality rate (CFR) was 0.54%. During June through August, H1N1 confirmed cases were infrequently detected, including only 30;however, from September through December, over 200 confirmed cases were reported each month. Of the 33 cases recorded, 25 were male (76%) and 8 were female (24%), male to female ratio being 3:1. Overall median age of the death cases was 30.8 years (range 1 - 55). The most common diagnosis upon admission was pneumonia. Out of the deaths, twenty five (75.8%) had no documented underlying diseases. Chronic cardiovascular disease (9.1%) was the most commonly reported disease and 2 deaths (6.1%) were recorded as pregnant women. Conclusions: The most common diagnosis upon admission was pneumonia. Chronic cardiovascular diseases were the most commonly reported underlying conditions, while the most identified risk factor was pregnancy. These findings should be taken into consideration, when vaccination strategies are employed. 展开更多
关键词 PANDEMIC INFLUENZA (H1N1) 2009 fatal caseS Yemen
暂未订购
Clinical features of 162 fatal cases of COVID-19:a multi-center retrospective study 被引量:1
2
作者 Xianlong Zhou Guoyong Ding +20 位作者 Qing Fang Jun Guo Luyu Yang Ping Wang Shou-Zhi Fu Ang Li Jian Xia Jiangtao Yu Jianyou Xia Min Ma Zhuanzhuan Hu Lei Huang Ruining Liu Cheng Jiang Shaoping Li Mingxia Yu Xizhu Xu Yan Zhao Quan Hu Weijia Xing Zhigang Zhao 《Emergency and Critical Care Medicine》 2022年第3期109-115,共7页
Background:The coronavirus disease 2019(COVID-19)has affected approximately 2 million individuals worldwide;however,data regarding fatal cases have been limited.Objective:To report the clinical features of 162 fatal c... Background:The coronavirus disease 2019(COVID-19)has affected approximately 2 million individuals worldwide;however,data regarding fatal cases have been limited.Objective:To report the clinical features of 162 fatal cases of COVID-19 from 5 hospitals in Wuhan between December 30,2019 and March 12,2020.Methods:The demographic data,signs and symptoms,clinical course,comorbidities,laboratory findings,computed tomographic(CT)scans,treatments,and complications of the patients with fatal cases were retrieved from electronic medical records.Results:The median patient age was 69.5(interquartile range:63.0–77.25)years,and 80%of the patients were over 61 years.A total of 112(69.1%)patients were men.Hypertension(45.1%)was the most common comorbidity,while 59(36.4%)patients had no comorbidity.At admission,131(81.9%)patients had severe or critical COVID-19,whereas 39(18.1%)patients with hypertension or chronic lung disease had moderate COVID-19.In total,126(77.8%)patients received antiviral treatment,while 132(81.5%)patients received glucocorticoid treatment.A total of 116(71.6%)patients were admitted to the intensive care unit(ICU),and 137(85.1%)patients received mechanical ventilation.Most patients received mechanical ventilation before ICU admission.Approximately 93.2%of the patients developed respiratory failure or acute respiratory distress syndrome.There were no significant differences in the inhospital survival time among the hospitals(P=0.14).Conclusion:Young patients with moderate COVID-19 without comorbidity at admission could also develop fatal outcomes.The in-hospital survival time of the fatal cases was similar among the hospitals of different levels in Wuhan. 展开更多
关键词 Clinical features Coronavirus disease 2019 fatal cases Survival time
原文传递
SEIHCRD Model for COVID-19 Spread Scenarios,Disease Predictions and Estimates the Basic Reproduction Number,Case Fatality Rate,Hospital,and ICU Beds Requirement 被引量:1
3
作者 Avaneesh Singh Manish Kumar Bajpai 《Computer Modeling in Engineering & Sciences》 SCIE EI 2020年第12期991-1031,共41页
We have proposed a new mathematical method,the SEIHCRD model,which has an excellent potential to predict the incidence of COVID-19 diseases.Our proposed SEIHCRD model is an extension of the SEIR model.Three-compartmen... We have proposed a new mathematical method,the SEIHCRD model,which has an excellent potential to predict the incidence of COVID-19 diseases.Our proposed SEIHCRD model is an extension of the SEIR model.Three-compartments have added death,hospitalized,and critical,which improves the basic understanding of disease spread and results.We have studiedCOVID-19 cases of six countries,where the impact of this disease in the highest are Brazil,India,Italy,Spain,the United Kingdom,and the United States.After estimating model parameters based on available clinical data,the modelwill propagate and forecast dynamic evolution.Themodel calculates the Basic reproduction number over time using logistic regression and the Case fatality rate based on the selected countries’age-category scenario.Themodel calculates two types of Case fatality rate one is CFR daily,and the other is total CFR.The proposed model estimates the approximate time when the disease is at its peak and the approximate time when death cases rarely occur and calculate how much hospital beds and ICU beds will be needed in the peak days of infection.The SEIHCRD model outperforms the classic ARXmodel and the ARIMA model.RMSE,MAPE,andRsquaredmatrices are used to evaluate results and are graphically represented using Taylor and Target diagrams.The result shows RMSE has improved by 56%–74%,and MAPE has a 53%–89%improvement in prediction accuracy. 展开更多
关键词 COVID-19 CORONAVIRUS SIER model SEIHCRD model parameter estimation mathematical model India Brazil United Kingdom United States Spain Italy hospital beds ICU beds basic reproduction number case fatality rate
暂未订购
Case Fatality Rate of Severe Acute Respiratory Syndromes in Beijing
4
作者 QI CHEN WAN-NIAN LIANG +5 位作者 GAI-FEN LIU MIN LIU XUE-QIN XIE JIANG WU XIONG HE ZE-JUN LIU 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2005年第4期220-226,共7页
To describe the case fatality rate of SARS in Beijing. Methods Data of SARS cases notified from Beijing Center for Disease Control and Prevention (BCDC) and supplemented by other channels were collected. The data we... To describe the case fatality rate of SARS in Beijing. Methods Data of SARS cases notified from Beijing Center for Disease Control and Prevention (BCDC) and supplemented by other channels were collected. The data were analyzed by rate calculation. Results The case fatality rate of SARS in Beijing was 7.66%, and had an ascending trend while the age of cases was getting older, and a descending trend while the epidemic developmem. The case fatality rate in Beijing was lower than that in other main epidemic countries or regions. Conclusions The risk of death increases with the increment of age of SARS patients. Beijing is successful in controlling and treating SARS. 展开更多
关键词 SARS case fatality rate BEIJING
暂未订购
A Study on the Global Scenario of COVID-19 Related Case Fatality Rate, Recovery Rate and Prevalence Rate and Its Implications for India—A Record Based Retrospective Cohort Study
5
作者 Vinod K. Ramani R. Shinduja +1 位作者 K. P. Suresh Radheshyam Naik 《Advances in Infectious Diseases》 2020年第3期233-248,共16页
<strong>Importance:</strong> Corona virus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pandemic claiming millions of lives since the first outbr... <strong>Importance:</strong> Corona virus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pandemic claiming millions of lives since the first outbreak was reported in Wuhan, China during December 2019. It is thus important to make cross-country comparison of the relevant rates and understand the socio-demographic risk factors. <strong>Methods: </strong>This is a record based retrospective cohort study. <strong>Table 1</strong> was extracted from <a href="https://www.worldometers.info/coronavirus/" target="_blank">https://www.worldometers.info/coronavirus/</a> and from the Corona virus resource center (<strong>Table 2</strong>, <strong>Figures 1-3</strong>), Johns Hopkins University. Data for <strong>Table 1</strong> includes all countries which reported >1000 cases and <strong>Table 2</strong> includes 20 countries reporting the largest number of deaths. The estimation of CFR, RR and PR of the infection, and disease pattern across geographical clusters in the world is presented. <strong>Results:</strong> From <strong>Table 1</strong>, we could infer that as on 4<sup>th</sup> May 2020, COVID-19 has rapidly spread world-wide with total infections of 3,566,423 and mortality of 248,291. The maximum morbidity is in USA with 1,188,122 cases and 68,598 deaths (CFR 5.77%, RR 15% and PR 16.51%), while Spain is at the second position with 247,122 cases and 25,264 deaths (CFR 13.71%, RR 38.75%, PR 9.78%). <strong>Table 2</strong> depicts the scenario as on 8<sup>th</sup> October 2020, where-in the highest number of confirmed cases occurred in US followed by India and Brazil (cases per million population: 23,080, 5007 & 23,872 respectively). For deaths per million population: US recorded 647, while India and Brazil recorded 77 and 708 respectively. <strong>Conclusion:</strong> Studying the distribution of relevant rates across different geographical clusters plays a major role for measuring the disease burden, which in-turn enables implementation of appropriate public healthcare measures. 展开更多
关键词 case fatality Rate COVID-19 Prevalence Rate Recovery Rate Statistical Analysis
暂未订购
Country-based modelling of COVID-19 case fatality rate:A multiple regression analysis
6
作者 Soodeh Sagheb Ali Gholamrezanezhad +2 位作者 Elizabeth Pavlovic Mohsen Karami Mina Fakhrzadegan 《World Journal of Virology》 2024年第1期84-94,共11页
BACKGROUND The spread of the severe acute respiratory syndrome coronavirus 2 outbreak worldwide has caused concern regarding the mortality rate caused by the infection.The determinants of mortality on a global scale c... BACKGROUND The spread of the severe acute respiratory syndrome coronavirus 2 outbreak worldwide has caused concern regarding the mortality rate caused by the infection.The determinants of mortality on a global scale cannot be fully understood due to lack of information.AIM To identify key factors that may explain the variability in case lethality across countries.METHODS We identified 21 Potential risk factors for coronavirus disease 2019(COVID-19)case fatality rate for all the countries with available data.We examined univariate relationships of each variable with case fatality rate(CFR),and all independent variables to identify candidate variables for our final multiple model.Multiple regression analysis technique was used to assess the strength of relationship.RESULTS The mean of COVID-19 mortality was 1.52±1.72%.There was a statistically significant inverse correlation between health expenditure,and number of computed tomography scanners per 1 million with CFR,and significant direct correlation was found between literacy,and air pollution with CFR.This final model can predict approximately 97%of the changes in CFR.CONCLUSION The current study recommends some new predictors explaining affect mortality rate.Thus,it could help decision-makers develop health policies to fight COVID-19. 展开更多
关键词 COVID-19 SARS-CoV-2 case fatality rate Predictive model Multiple regression
暂未订购
死亡率(mortality)和病死率(case fatality rate)
7
《广州医学院学报》 2006年第5期25-25,共1页
关键词 病死率 case fatality rate MORTALITY 死亡率 RATE
暂未订购
Crizotinib-induced acute fatal liver failure in an Asian ALK-positive lung adenocarcinoma patient with liver metastasis: A case report 被引量:1
8
作者 Ying Zhang Yan-Yan Xu +2 位作者 Yi Chen Jin-Na Li Ying Wang 《World Journal of Clinical Cases》 SCIE 2019年第9期1080-1086,共7页
BACKGROUND Crizotinib-induce hepatotoxicity is rare and non-specific, and severe hepatotoxicity can develop into fatal liver failure. Herein, we report a case of fatal crizotinib-induced liver failure in a 37-year-old... BACKGROUND Crizotinib-induce hepatotoxicity is rare and non-specific, and severe hepatotoxicity can develop into fatal liver failure. Herein, we report a case of fatal crizotinib-induced liver failure in a 37-year-old Asian patient.CASE SUMMARY The patient complained of dyspnea and upper abdominal pain for a week in August 2017. He was diagnosed with anaplastic lymphoma kinase-rearranged lung adenocarcinoma combined with multiple distant metastases. Crizotinib was initiated as a first-line treatment at a dosage of 250 mg twice daily. No adverse effects were seen until day 46. On day 55, he was admitted to the hospital with elevated liver enzymes aspartate aminotransferase(AST)(402 IU/L), alanine aminotransferase(ALT)(215 IU/L) and total bilirubin(145 μmol/L) and was diagnosed with crizotinib-induced fulminant liver failure. Despite crizotinib discontinuation and intensive supportive therapy, the level of AST(1075 IU/L),ALT(240 IU/L) and total bilirubin(233 μmol/L) continued to rapidly increase,and he died on day 60.CONCLUSION Physicians should be aware of the potential fatal adverse effects of crizotinib. 展开更多
关键词 fatal LIVER failure CRIZOTINIB HEPATOTOXICITY LIVER METASTASES ALK rearrangement Lung adenocarcinoma case report
暂未订购
Subgroup comparison of COVID-19 case and mortality with associated factors in Mississippi: findings from analysis of the first four months of public data 被引量:1
9
作者 Lei Zhang Stephanie T.McLeod +3 位作者 Rodolfo Vargas Xiaojian Liu Dorthy K.Young Thomas E.Dobbs 《The Journal of Biomedical Research》 CAS CSCD 2020年第6期446-457,共12页
We compared subgroup differences in COVID-19 case and mortality and investigated factors associated with case and mortality rate(MR)measured at the county level in Mississippi.Findings were based on data published by ... We compared subgroup differences in COVID-19 case and mortality and investigated factors associated with case and mortality rate(MR)measured at the county level in Mississippi.Findings were based on data published by the Mississippi State Department of Health between March 11 and July 16,2020.The COVID-19 case rate and case fatality rate(CFR)differed by gender and race,while MR only differed by race.Residents aged 80 years or older and those who live in a non-metro area had a higher case rate,CFR,and MR.After controlling for selected factors,researchers found that the percent of residents who are obese,low income,or with certain chronic conditions were associated with the county COVID-19 case rate,CFR,and/or MR,though some were negatively related.The findings may help the state to identify counties with higher COVID-19 case rate,CFR,and MR based on county demographics and the degree of its chronic conditions. 展开更多
关键词 COVID-19 case rate case fatality rate mortality rate
暂未订购
Tuberculosis septic shock, an elusive pathophysiology and hurdles in management: A case report and review of literature 被引量:3
10
作者 Rashmi Mishra Harish K Patel +1 位作者 Rakesh Singasani Trupti Vakde 《World Journal of Critical Care Medicine》 2019年第5期72-81,共10页
BACKGROUND Tuberculosis (TB) is a rare etiology of the septic shock. Timely administration of the anti-microbial agents has shown mortality benefit. Prompt diagnosis and a high index of suspicion are crucial to the ma... BACKGROUND Tuberculosis (TB) is a rare etiology of the septic shock. Timely administration of the anti-microbial agents has shown mortality benefit. Prompt diagnosis and a high index of suspicion are crucial to the management. We present three cases of TBSS with poor outcome in the majority despite timely and susceptible antibiotic administration. CASE SUMMARY Sixty-seven-year-old woman with latent TB presented with fever, cough, and shortness of breath. She was promptly diagnosed with active TB and started on the appropriate anti-microbial regimen;she had a worsening clinical course with septic shock and multi-organ failure after initiation of antibiotics. Thirty-threeyear- old man immunocompromised with acquired immune deficiency syndrome presented with fever, anorexia and weight loss. He had no respiratory symptoms, and first chest X-ray was normal. He had enlarged liver, spleen and lymph nodes suspicious for lymphoma. Despite broad-spectrum antibiotics, he succumbed to refractory septic shock and multi-organ failure. It was shortly before his death that anti-TB antimicrobials were initiated based on pathology reports of bone marrow and lymph node biopsies. Forty-nine-year-old woman with asthma and latent TB admitted with cough and shortness of breath. Although Initial sputum analysis was negative, a subsequent broncho-alveolar lavage turned out to be positive for acid fast bacilli followed by initiation of susceptible ant-TB regimen. She had a downward spiral clinical course with shock, multi-organ failure and finally death. CONCLUSION Worse outcome despite timely initiation of appropriate antibiotics raises suspicion of TB immune reconstitution as a possible pathogenesis for TB septic shock. 展开更多
关键词 TUBERCULOSIS SEPTIC shock TUBERCULOSIS and immune RECONSTITUTION TUBERCULOSIS in intensive care unit case fatalITY for TUBERCULOSIS SEPTIC shock case report
暂未订购
2021-2023年某三级综合性医院819例住院死亡病例分析 被引量:1
11
作者 曾添福 吴巧莉 +1 位作者 童霄毅 马戈 《中国医院统计》 2025年第2期136-139,共4页
目的回顾分析某三级综合性医院住院死亡病例,以了解和掌握近年来某院住院病人的死亡情况及其原因,为医院提供科学合理的管理依据。方法收集某三级综合性医院2021-2023年住院死亡病例,从年龄、性别、科室、死亡疾病诊断等情况进行回顾性... 目的回顾分析某三级综合性医院住院死亡病例,以了解和掌握近年来某院住院病人的死亡情况及其原因,为医院提供科学合理的管理依据。方法收集某三级综合性医院2021-2023年住院死亡病例,从年龄、性别、科室、死亡疾病诊断等情况进行回顾性分析。结果该医院2021-2023年死亡病例819例,总住院病死率0.58%,男女比例1.96:1,60岁及以上占比82.42%,死亡科室主要以ICU、心血管内科、呼吸科、神经外科为主,疾病前3位为肿瘤、循环系统及呼吸系统疾病。结论随着人口老龄化的加重,肿瘤、循环系统及呼吸系统疾病成为本院住院死亡的主要原因,老年患者是需要重点关注的对象。 展开更多
关键词 住院死亡 病死率 死因分析
暂未订购
2016—2022年某三甲医院805例慢性病住院死亡病例回顾性分析
12
作者 卿雪莲 陈小玉 +2 位作者 廖娟 胡良波 周雄 《右江医学》 2025年第3期214-220,共7页
目的探讨某医院慢性病住院死亡患者特征、死因构成及分布,为降低医院病死率提供依据。方法根据国际疾病分类(ICD-10)编码明确死因并分类,通过回顾性研究的方法对2016—2022年某医院805例慢性病住院死亡病例资料进行统计描述与分析,比较... 目的探讨某医院慢性病住院死亡患者特征、死因构成及分布,为降低医院病死率提供依据。方法根据国际疾病分类(ICD-10)编码明确死因并分类,通过回顾性研究的方法对2016—2022年某医院805例慢性病住院死亡病例资料进行统计描述与分析,比较死亡病例年龄、性别、死因分布。结果2016—2022年慢性病住院患者病死率为0.23%(805/351555),男性病死率为0.30%(557/184345),显著高于女性的0.15%(248/167210),不同性别病死率存在统计学意义(χ^(2)=90.824,P<0.001)。不同年龄慢性病住院患者病死率呈上升趋势,其中60~<75岁病死率为0.26%,≥75岁病死率为0.75%。慢性病住院患者病死率前三位死因为心脑血管疾病、呼吸系统疾病与肿瘤。结论心脑血管疾病、呼吸系统疾病与肿瘤是主要致死疾病,应加强重点高风险人群筛查和健康教育,提高健康水平。 展开更多
关键词 住院患者 慢性病 病死率 死因顺位 根本死因
暂未订购
1968—2023年杭州某区职业性尘肺病患者特征分析
13
作者 丁百旺 翁健 +3 位作者 吴翔菊 孙腾云 陈双燕 洪密 《环境与职业医学》 北大核心 2025年第9期1094-1098,1107,共6页
[背景]尘肺病是影响我国职业人群健康的第一大职业病,发病人数仍居首位,目前尘肺病发病特征及生存影响因素分析较少。[目的]分析临安区尘肺病患者发病特征及生存影响因素,为当地尘肺病防治提供理论依据。[方法]通过职业病及健康危害因... [背景]尘肺病是影响我国职业人群健康的第一大职业病,发病人数仍居首位,目前尘肺病发病特征及生存影响因素分析较少。[目的]分析临安区尘肺病患者发病特征及生存影响因素,为当地尘肺病防治提供理论依据。[方法]通过职业病及健康危害因素监测信息系统、历年诊断资料、公安、社保、民政以及慢病死亡系统等相关渠道收集临安区确诊尘肺病患者信息及生存资料。分别采用单因素方差分析对尘肺病类别、接尘工龄、存活情况等相关信息进行比较分析,生存资料采用Cox回归分析。[结果] 1968—2023年临安区共报告尘肺病患者92例,全部为男性,矽肺占比最高(82.61%),尘肺病诊断年龄以40~60岁为主(73.91%),接尘工龄大多在10~20年(41.30%),发病行业集中在采矿业和金属制造业(76.09%)。尘肺病患者平均死亡年龄为(69.19±10.78)岁,主要死亡原因为呼吸系统疾病和癌症(51%),尘肺病期别和是否有社会保障对尘肺病患者生存时间有影响,接尘工龄和尘肺病种类对患者生存时间无影响。[结论]临安区尘肺病患者以矽肺为主,应加强对粉尘危害严重行业治理和监管,同时做好确诊患者康复保障工作,进一步提高尘肺病患者生活质量。 展开更多
关键词 尘肺病 矽肺 生存分析 死亡病例 死因
原文传递
Using X Social Networks and web news mining to predict Marburg virus disease outbreaks
14
作者 Mohammad Jokar Kia Jahanbin Vahid Rahmanian 《Asian Pacific Journal of Tropical Medicine》 2025年第2期96-98,共3页
Marburg virus disease(MVD)is a highly fatal illness,with a case fatality rate of up to 88%,though this rate can be significantly reduced with prompt and effective patient care.The disease was first identified in 1967 ... Marburg virus disease(MVD)is a highly fatal illness,with a case fatality rate of up to 88%,though this rate can be significantly reduced with prompt and effective patient care.The disease was first identified in 1967 during concurrent outbreaks in Marburg and Frankfurt,Germany,and in Belgrade,Serbia,linked to laboratory use of African green monkeys imported from Uganda.Subsequent outbreaks and isolated cases have been reported in various African countries,including Angola,the Democratic Republic of the Congo,Equatorial Guinea,Ghana,Guinea,Kenya,Rwanda,South Africa(in an individual with recent travel to Zimbabwe),Tanzania,and Uganda.Initial human MVD infections typically occur due to prolonged exposure to mines or caves inhabited by Rousettus aegyptiacus fruit bats,the natural hosts of the virus. 展开更多
关键词 laboratory use marburg virus disease mvd african green monkeys outbreaks social networks marburg virus disease case fatality rate web news mining
暂未订购
某地市三甲医院2019-2023年住院死亡病例统计分析
15
作者 邹芳 路健祺 +1 位作者 董耀文 王涵嫣 《中国医院统计》 2025年第5期380-384,共5页
目的对某地市三甲医院2019—2023年2789例死亡病例进行回顾性分析,探索死亡患者相关因素,为持续提升救治水平,降低病死率提供参考依据。方法利用病案统计系统收集2019—2023年间住院病案首页信息,结合国际疾病分类规则,使用Excel2007和S... 目的对某地市三甲医院2019—2023年2789例死亡病例进行回顾性分析,探索死亡患者相关因素,为持续提升救治水平,降低病死率提供参考依据。方法利用病案统计系统收集2019—2023年间住院病案首页信息,结合国际疾病分类规则,使用Excel2007和SPSS19.0软件对2789例死亡患者资料进行统计分析。采用统计图表描述不同年度,性别,年龄,急、危重症患者,低风险组病死率分布差异;分析住院死亡患者主要死因疾病分类构成及顺位、主要死因的病种构成及顺位,并用χ^(2)检验进行组间比较。结果该院2019—2023的5年间病死率为0.61%,住院患者男女比例为1∶1.07;男性患者病死率为0.80%,女性患者为0.43%;死亡患者年龄分布最高的为81岁及以上群组(3.2%),其次为71~80岁(1.11%)。死亡人数构成比最高的是71~80岁(24.60%),其次是61~70岁(22.30%);死亡原因构成比排名前3位的疾病分类分别是肿瘤(29.94%)、循环系统疾病(28.11%)、呼吸系统疾病(11.98%);死因病种前3位分别是急性心机梗死、肺癌、颅内损伤;入院病情急的病死率最高(5.51%),其次是入院病情危的病死率(0.67%);5年间低风险组死亡患者共88例,低风险组病死率为0.36‰,5年间低风险组病死率最高为2022年(0.64‰),最低为2023年(0.11‰)。结论为提升三级公立医院疾病诊疗的综合服务能力,应优化医院资源配置,加强肿瘤科、心血管科及危重症科等科室的学科建设及专科服务能力建设,持续提升疑难危重疾病诊治能力及水平,推进医院高质量发展。 展开更多
关键词 死亡病例 病死率 疾病分类 统计分析
暂未订购
2019—2023年四川省某三甲医院住院患者死亡病例分析
16
作者 邓永平 黄刚 +2 位作者 唐莉 屈航 杨帆 《现代医院》 2025年第9期1433-1437,共5页
目的分析某三甲医院死亡病例特征,为医院管理决策和诊疗服务效果评价提供参考。方法通过医院住院病案信息系统导出2019—2023年该院的住院患者死亡病例信息,采用临床流行病学方法对住院死亡患者的病案进行回顾性统计分析。结果2019—202... 目的分析某三甲医院死亡病例特征,为医院管理决策和诊疗服务效果评价提供参考。方法通过医院住院病案信息系统导出2019—2023年该院的住院患者死亡病例信息,采用临床流行病学方法对住院死亡患者的病案进行回顾性统计分析。结果2019—2023年该院累计收治住院患者459821例,死亡3250例,病死率为0.71%。病死率从2019年的0.71%降至2023年的0.63%,呈递减趋势,但差异无统计学意义(APC=-3.17,P>0.05)。男性病死率0.97%,女性病死率0.45%,男性病死率高于女性(χ^(2)=435.206,P<0.05)。死亡病例平均年龄为(69.59±17.70)岁,病死率随着年龄增长逐渐升高,≥80岁年龄组病死率最高,为2.98%。不同年龄组患者病死率差异有统计学意义(χ^(2)=3502.991,P<0.05)。住院死亡患者前5位死因依次为肿瘤、循环系统疾病、呼吸系统疾病、某些传染病和寄生虫病及损伤、中毒和外因作用,占总死亡人数的87.33%。其中肿瘤的主要死因为支气管和肺恶性肿瘤、肝和肝内胆管恶性肿瘤、胃恶性肿瘤;循环系统的主要死因为脑梗死、急性心肌梗死及脑内出血;呼吸系统的主要死因为病原体未特指肺炎、细菌性肺炎、其他慢性阻塞性肺病。结论该院住院患者中男性及≥80岁年龄组人群的病死率较高,肿瘤、循环系统疾病、呼吸系统疾病是主要的死亡原因。医院应根据患者的年龄、性别及所患疾病的特点,科学合理配置医疗资源;根据死因顺位及分布情况,加强对肿瘤、循环系统疾病、呼吸系统疾病的防治工作,提升诊疗水平,降低住院患者病死率。 展开更多
关键词 死亡病例 病死率 死因顺位
暂未订购
人类免疫缺陷病毒感染者、非人类免疫缺陷病毒感染者合并隐球菌性脑膜炎临床特征对比分析
17
作者 陶燕萍 许序云 +2 位作者 尹正元 陈静 章小凡 《传染病信息》 2025年第2期128-133,共6页
目的探讨艾滋病患者、非人类免疫缺陷病毒(human immunodeficiency virus,HIV)感染者在合并隐球菌性脑膜炎(cryptococcal meningitis,CM)时的临床特征差异。方法对昆明市第三人民医院2020年1月至2021年6月期间收治的80例CM患者临床资料... 目的探讨艾滋病患者、非人类免疫缺陷病毒(human immunodeficiency virus,HIV)感染者在合并隐球菌性脑膜炎(cryptococcal meningitis,CM)时的临床特征差异。方法对昆明市第三人民医院2020年1月至2021年6月期间收治的80例CM患者临床资料进行回顾性分析,按照是否合并HIV感染分为HIV感染组(n=50)和非HIV感染组(n=30),对比2组患者的年龄、性别、基础性疾病、风险因素、病程、临床表现及首次入院实验室指标,并比较治疗方法与转归;并对比症状、病程、首次腰穿检查、基础性疾病以及CD4^(+)T细胞计数方面的差异;比较30d病死率和90d病死率。所有患者均随访跟踪1年。结果HIV感染组CD4^(+)T细胞计数低于非HIV感染组(P<0.05);非HIV感染组使用糖皮质激素,合并肝硬化、慢性肾脏疾病、自身免疫性疾病、恶性肿瘤的患者比例均显著高于HIV感染组,差异均具有统计学意义(P均<0.05)。HIV感染组患者发病至确诊时间显著短于非HIV感染组(P<0.05)HIV感染组患者颅内压、脑脊液白细胞、脑脊液葡萄糖水平均低于非HIV感染组,而隐球菌血症发生率、脑脊液培养阳性率高于非HIV感染组,差异均具有统计学意义(P均<0.05)。多因素Logistic回归分析结果显示:CD4^(+)T细胞计数、自身免疫性疾病、颅内压、脑脊液白细胞、脑脊液葡萄糖、脑脊液培养阳性为HIV感染者发生CM的危险因素。(P均<0.05)。HIV感染组30d、90d病死率均高于非HIV感染组,治疗有效率低于非HIV感染组,差异均具有统计学意义(P均<0.05)。结论HIV感染显著影响CM患者临床特征与转归,HIV感染者表现出更为严重的临床症状、较高的死亡率,且免疫抑制程度越重,预后越差。 展开更多
关键词 人类免疫缺陷病毒 隐球菌脑膜炎 临床特征 病死率
暂未订购
桥接法取栓对急性后循环缺血性脑卒中患者90 d内病死率的影响
18
作者 王小燕 赵丽丽 +1 位作者 栗冰霞 张丽芳 《中国急救复苏与灾害医学杂志》 2025年第11期1439-1443,共5页
目的观察桥接法取栓用于急性后循环缺血性脑卒中(APCIS)患者的效果。方法回顾性研究。选择2021年4月—2023年4月长治市人民医院收治的APCIS患者208例,按治疗方法不同分为两组,对照组101例采用阿替普酶静脉溶栓,研究组107例在阿替普酶静... 目的观察桥接法取栓用于急性后循环缺血性脑卒中(APCIS)患者的效果。方法回顾性研究。选择2021年4月—2023年4月长治市人民医院收治的APCIS患者208例,按治疗方法不同分为两组,对照组101例采用阿替普酶静脉溶栓,研究组107例在阿替普酶静脉溶栓基础上桥接Captor支架取栓。比较两组美国国立卫生院卒中量表(NIHSS)评分、血管再通率、并发症发生情况、90 d内病死率,并检测血清神经肽Y、S100β、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)水平。采用Logistic回归分析筛选APCIS患者90 d内病死的影响因素。结果治疗后,两组NIHSS评分、神经肽Y、S100β、TNF-α、IL-6[对照组:(14.94±2.46)分、(179.65±32.64)ng/L、(1.59±0.52)μg/L、(3.01±0.57)ng/mL、(113.43±16.48)pg/mL;研究组:(11.85±2.02)分、(145.14±30.72)ng/L、(1.07±0.33)μg/L、(2.22±0.46)ng/mL、(104.94±14.47)pg/mL]均低于治疗前[对照组:(20.72±3.28)分、(226.71±36.25)ng/L、(3.94±1.21)μg/L、(5.15±1.24)ng/mL、(135.84±20.25)pg/mL;研究组:(20.21±3.53)分、(228.58±38.51)ng/L、(4.03±1.18)μg/L、(5.07±1.32)ng/mL、(133.47±18.92)pg/mL](对照组t=35.104、24.978、36.167、32.578、21.832;研究组t=47.851、44.143、44.252、39.676、30.875;均P<0.05),且研究组低于对照组(t=9.924、7.855、8.661、11.029、3.954,均P<0.05)。研究组的血管再通率85.98%高于对照组70.30%(χ²=7.539,P<0.05)。研究组的并发症总发生率9.35%、90 d内病死率7.48%低于对照组的22.77%、16.83%(χ²=7.017、4.300,均P<0.05)。治疗前NIHSS评分高(95%CI:2.152~7.940,P<0.001)、血管再通情况“无效开通”(95%CI:2.263~6.223,P<0.001)是APCIS患者90 d内病死的独立危险因素,治疗方法采用“阿替普酶静脉溶栓基础上桥接Captor支架取栓”(95%CI:0.459~0.915,P=0.014)是保护因素。结论桥接法取栓能改善APCIS患者的神经功能,提高血管再通率,减少并发症发生,降低90 d内病死率,且能调节神经肽Y、S100β、TNF-α、IL-6。治疗前NIHSS评分高、血管再通情况“无效开通”是APCIS患者90 d内病死的独立危险因素,治疗方法采用“阿替普酶静脉溶栓基础上桥接Captor支架取栓”是保护因素。 展开更多
关键词 桥接法取栓 急性后循环缺血性脑卒中 病死率 影响因素
暂未订购
上一页 1 2 13 下一页 到第
使用帮助 返回顶部